TLR4 and autoimmune thrombocytopenic purpura: IVIg was able to significantly ameliorate thrombocytopenia in both mouse strains, with no significant difference in platelet numbers in C3H/HeJ mice vs C3H/HeNCrl mice, suggesting that IVIg can function in the absence of this TLR4 signaling pathway in murine passive ITP.